Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Jan 07, 2026, 10:32 ET How $594B in Precision Tech is Cracking the Metastatic Cancer Code
"reprogramming" the body's defenses drives the investment case for Oncolytics Biotech Inc. (NASDAQ: ONCY), BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT), Greenwich LifeSciences, Inc. (NASDAQ: GLSI), Citius Oncology (NASDAQ: CTOR), and Kazia Therapeutics Limited (NASDAQ:
More news about: USA News Group